Now Location：Home--News Center--Company News
At this happy moment of the centennial founding of the CPC, Weihe Biology also ushered in a new page of development. On July 1, 2021, the administrative office area and inspection and testing center of Weihe Biotechnology were relocated to Building 2 of the China Pharmaceutical City Phase VI Standard Factory. The opening of the new site has added 2000 square meters of inspection and testing center and 2000 square meters of administrative office area for Weihe Biotechnology, which can meet Weihe Biotechnology's business strategy model of "dual wheel drive" (product+service) and development needs in the past three years.
Since 2021, Weihe Biotechnology has successively completed a second round of financing of tens of millions of yuan, the construction of a new headquarters in Taizhou, Jiangsu, and the commencement of construction of the Yibin Regional Center in Sichuan. With the support of capital and resources, Weihe Biotechnology has embarked on a fast track of development. Actively participated in the formulation of relevant product national standards and the joint research of national reference materials on the transplant diagnosis product line, and successfully entered the procurement catalog of some important transplant hospitals; On the blood transfusion molecular diagnosis product line, we have successfully won bids or cooperated with more than 20 large blood centers and central blood stations, and cooperation with clinical hospitals has also sprung up like mushrooms after rain. The company's team continues to grow and expand, with personnel coverage completed in areas such as Wuhan, Changsha, Zhengzhou, and Shijiazhuang; The cooperation with partners such as Beijing Baode Group, Suzhou Ankai Life Technology, Beijing Jingzhun Medical Technology, and Guangzhou Zhili Medical Diagnosis has been in full swing.
In the first half of the year, with the efforts of all employees, the assistance of partners, and the support of numerous customers, Weihe has made certain progress. In the second half of the year, we will continue to work hard, further accelerate development progress, and achieve greater development goals.
